张东晓

2017-06-23


张东晓博士现任美国BlueJay Mobile-Health公司创始人,总裁兼董事长,中国江苏华泰晨光药业董事长,美国太平洋大学药学院兼职教授。

曾是美国Formurex公司的创始人、兼总裁 (www.formurex.com)。在Formurex之前,张博士还是Epitomics公司的共同创始人( www.epitomics.com) 兼副总裁。

张博士是多项技术的发明人,拥有十多项授权专利,曾获百余万美元的美国政府研究经费。

张博士于1996年在Case Western University 获生化博士学位,之后在Genentech 公司做博士后。在建立Epitomics之前,曾在拜耳制药(Bayer Corporation)担任资深研究科学家,在医药行业拥有20余年的工作经验。

张博士在美国加利福尼亚圣玛丽 (St. Mary’s College)商学院获管理硕士。

 Dr. Zhang Dongxiao is the founder, president and chairman of BlueJay Mobile-Health, the chairman of Jiangsu Huatai Chenguang Pharmaceutical Inc. and a part-time professor of the School of Pharmacy, Pacific University.

He is the former founder and president of Formousx Inc. (www.formurex.com).

Prior to Formurex, Dr. Zhang was the co-founder and vice president of Epitomics Inc. (www.epitomics.com).

Dr. Zhang is the inventor of a number of technologies, with more than 10 authorized patents, and won the US government research funding of more than one million US dollars.

Dr. Zhang received a PhD degree in biochemistry from Case Western University in 1996, and later worked as a post-doctor at Genentech. Prior to the establishment of Epitomics, he was a senior research scientist at Bayer Corporation.

Dr. Zhang has more than 20 years of experience in the pharmaceutical industry.

Dr. Zhang holds a Master’s degree of Management at St. Mary's College Business School in California, US.

上一篇:陈宏武
下一篇:张爱国
Powered by 飞色网络